Chinese Beansprout, LLC in Denver, Colorado receives FDA inspection

Chinese Beansprout, LLC in Denver, Colorado receives FDA inspection
-
0Comments

Chinese Beansprout, LLC in Denver, Colorado was inspected by the Food and Drug Administration (FDA) on July 16 for foodborne biological hazards and received one citation, according to data posted on the FDA’s official website.

The FDA website shows that the company was cited for the following problem: ‘You did not test for Listeria spp. or Listeria monocytogenes in your growing, harvesting, packing and holding environment.’

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency that is primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.



Related

Caleb Michaud, Acting Associate Commissioner for External Affairs of FDA

FDA inspects Silver Canyon Coffee in Boulder for compliance on April 22

FDA records note an inspection at Silver Canyon Coffee in Boulder conducted on April 22, focusing on food composition, standards, labeling, economics, and biological hazards associated with foodborne illnesses.

Jim Traficant, Chief of Staff of FDA

FDA cites Silver Canyon Coffee in Boulder during April 22 inspection

The Food and Drug Administration conducted an inspection of Silver Canyon Coffee in Boulder on April 22, citing the business once for plant maintenance issues and reviewing food standards, labeling and biological hazards, based on information from the FDA’s official website.

Dr. Mehmet Oz CMS Administrator

Alcohol and drug abuse treatment Medicaid spending in Boulder surges to nearly $500,000 in 2024

Boulder saw Medicaid spending for Alcohol and Drug Abuse Treatment services jump by 91.7% to $499,954 in 2024, highlighting changing service use and payment trends in the city.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Boulder Leader.